ARGUS Upgrades Integra LifeSciences (IART) to Buy
Tweet Send to a Friend
ARGUS upgrades Integra LifeSciences Holdings (Nasdaq: IART) from Hold to Buy. Price target $57.
ARGUS analyst says ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
ARGUS analyst says ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE